About Us

Cymra Life Sciences is an Australian owned licenced importer and manufacturer of medical cannabis. We’ve set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.

We are focused on the development of cannabis medicines for chronic and neuropathic pain.

WHY? We don’t believe there is good long term medication options for chronic pain conditions (i.e opiates) are a good long term medication and have serious side effects.

We’re one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method which delivers a consistent, natural product, free from pests and chemical dependencies.

The team at Cymra Life Sciences is innovative, ambitious and fast-moving, all backed up by years of experience across pain management, medical research, plant genetics and breeding.

 

Why Tissue Culture?

PLANT QUALITY

Tissue culture propagation creates unique high health plants, free from pests & diseases.

CONSISTENT GENETICS

Through cultivation a plant can be reproduced with identical genetics allowing for consistent whole plant cannabis.

GREATER PRODUCTION

Tissue Culture is able to cultivate greater quantities over traditional propagation methods.

FASTER GROWTH

With less exposure to pests and diseases, tissue culture plants grow more vigorously.

Our Strategic Pillars

Genetics-and-tissue-culture

Genetics & Tissue Culture

Scientific & Clinical Research

CONDITION-BASED-PHARMACEUTICAL-FORMULATIONS

Condition Based Pharmaceutical Formulations

PARTNERSHIPS-DISTRIBUTION �

Partnerships & Distribution

EXPERIENCED BOARD-ADVISORY-TEAM

Experienced Board & Advisory Team